Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche Endosteal
Sponsor: Centre Hospitalier Universitaire de Nice
Terminated
the investigator has left the hospital
Other terminated trials from Centre Hospitalier Universitaire de Nice
- Diabetic Cardiomyopathies · Phase NA · Dec 2023
- Escherichia Coli Infections · Sep 2023
- Healthy Volunteers · Phase NA · Jul 2023
- Chronic Kidney Disease · Phase NA · Dec 2022
- Premature Birth · Phase NA · Sep 2022
See all terminations from Centre Hospitalier Universitaire de Nice
Other Myeloproliferative Disorders trials with similar outcome
This observational or N/A phase trial investigates Myeloproliferative Disorders and is currently terminated or withdrawn. Centre Hospitalier Universitaire de Nice leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Mar 2024 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Dec 2021 — Mar 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2018 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nice
- Centre National de la Recherche Scientifique, France
For direct contact, visit the study record on ClinicalTrials.gov .